Gain Therapeutics, Inc. (GANX) Operating Margin % [USD] 2020 - 2022

Historical data

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Gain Therapeutics, Inc. annual/quarterly Operating Margin history and growth rate from 2020 to 2022.
  • Gain Therapeutics, Inc. Operating Margin for the quarter ending June 30, 2022 was -7.74 K %, a 1.45% decline year-over-year.
  • Gain Therapeutics, Inc. annual Operating Margin for 2023 was -40.3 K %, a 218% decline from 2022.
  • Gain Therapeutics, Inc. annual Operating Margin for 2022 was -12.7 K %, a 51.4% decline from 2021.
  • Gain Therapeutics, Inc. annual Operating Margin for 2021 was -8.38 K %, a 30.4% increase from 2020.
Operating Margin, Quarterly (% [USD])
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2022 -7.74 K -110 -1.45% Apr 1, 2022 Jun 30, 2022
Q1 2022 -7.15 K +12.6 K +63.8% Jan 1, 2022 Mar 31, 2022
Q4 2021 -8.38 K +3.67 K +30.4% Oct 1, 2021 Dec 31, 2021
Q3 2021 -9.34 K Jul 1, 2021 Sep 30, 2021
Q2 2021 -7.63 K Apr 1, 2021 Jun 30, 2021
Q1 2021 -19.8 K Jan 1, 2021 Mar 31, 2021
Q4 2020 -12 K Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.